Icecure Medical (ICCM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist

0.599
-0.004-0.66%

Trading Nov 21 13:24 ET

33.22MMarket Cap-2063P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: ICCM to Report Financial Results Pre-market on November 26
Moomoo NewsNov 20 10:45 ET
IceCure's ProSense Chosen For Breast Cryoablation Study Led By The European Institute Of Oncology With Sponsorship From The Italian Ministry Of Health
BenzingaNov 19 08:32 ET
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3
Moomoo NewsNov 9 15:31 ET · Ratings
IceCure Gets Favorable FDA AdCom Vote for ProSense System
Seeking AlphaNov 8 10:48 ET
Positive Outlook for IceCure Medical Driven by FDA Panel Support and Market Authorization
TipRanksNov 8 07:22 ET
Express News | Icecure Medical Ltd - FDA Decision on Marketing Authorization Expected in Q1 of 2025
ReutersNov 8 07:00 ET

Comments

Trytosaveabit

Nov 19 07:36

Update

$Icecure Medical (ICCM.US)$ IceCure's ProSense Chosen For Breast Cryoablation Study Led By The European Institute Of Oncology With Sponsorship From The Italian Ministry Of Health
Benzinga· 3 mins ago
PRECICE study, financed by the Umberto Veronesi Foundation and the Italian Ministry of Health, is led by multidisciplinary collaborators including breast surgeons, interventional radiologists, and breast imaging and pathology specialists
PRECICE is exclusively using ProSense to treat all 233 Lu...

Jaguar8

Nov 19 07:31

NEWS

$Icecure Medical (ICCM.US)$
IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of Health
IceCure Medical's ProSense® has been selected for the PRECICE study, a major breast cryoablation research initiative led by the European Institute of Oncology. The study, sponsored by the Umberto Veronesi Foundation and Italian Ministry of Health, will exclusively use ProSense® to treat 233 patients aged...

Trytosaveabit

Nov 8 06:02

Update

$Icecure Medical (ICCM.US)$ Reuters
1 min ago
FDA Advisory Panel Votes in Favor of Icecure's Prosense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer